Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
eCLEAR: Romidepsin and 3BNC117 in HIV-1
NCT03041012Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Jan 2017
- Primary completion
- Aug 2021
- Modality
- Anti-infectious Disease mAbs, Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of romidepsin, Teropavimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Aarhus University Hospital. Started Jan 2017; status: completed.
02
Drugs
romidepsinTeropavimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03041012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03041012.